PRQR

$1.94-2.51%website ↗

ProQR Therapeutics N.V.

Market Cap

$210M

Sector

Materials

Industry

Biotechnology

Beta

0.22

5yr monthly vs SPY

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

15 analysts

Velocity Score

24.85x

Current Rate (90d)

6666.67/mo

Baseline Rate

0.00/mo

Unique Buyers (90d)

2

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-07-17	2026-07-21	Filius Bart	Director	Purchase	150.0K	$1.72	$258K	300.0K	View
2026-07-09	2026-07-13	de Boer Daniel Anton	Director & Chief Executive Officer	Purchase	150.0K	$1.74	$261K	300.0K	View
2026-07-07	2026-07-08	de Boer Daniel Anton	Director & Chief Executive Officer	Purchase	150.0K	$1.59	$239K	150.0K	View
2026-06-26	2026-06-30	Filius Bart	Director	Purchase	150.0K	$1.54	$231K	150.0K	View

Recent News

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

Yahoo · 2026-09-09

ProQR to Participate in Upcoming Investor Conferences in September 2026

Yahoo · 2026-09-02

ProQR Therapeutics: Buy For Axiomer RNA Tech Validation And Other Catalysts

SeekingAlpha · 2026-08-21

Coty Posts Mixed Q4 Results, Joins Wolfspeed, ATRenew And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

Benzinga · 2026-08-20

Informational purposes only, not investment advice.